Clients not fleeing Swiss banks over tax deals
GENEVA (Reuters) - There will be no mass exodus of clients from Switzerland's banks due to deals with several European countries over untaxed assets stashed in secret accounts and a...
Home > Reviews
All Stories
Clients not fleeing Swiss banks over tax deals
GENEVA (Reuters) - There will be no mass exodus of clients from Switzerland's banks due to deals with several European countries over untaxed assets stashed in secret accounts and a...
Actelion sees no earnings growth until 2014
ZURICH (Reuters) - Europe's biggest biotech company Actelion said it would only return to earnings growth in 2014, later than analysts expect, as new medicines and cost cuts would take...
Actelion sees no earnings growth until 2014
ZURICH (Reuters) - Europe's biggest biotech company Actelion said it would only return to earnings growth in 2014, later than analysts expect, as new medicines and cost cuts would take...
Roche Q1 sales solid as Illumina bid battle rages
ZURICH (Reuters) - Swiss drugmaker Roche said it would have to rethink its tactics if shareholders of reluctant U.S. bid target Illumina did not back its approach as it reported...
Roche Q1 sales solid as Illumina bid battle rages
ZURICH (Reuters) - Swiss drugmaker Roche said it would have to rethink its tactics if shareholders of reluctant U.S. bid target Illumina did not back its approach as it reported...